Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?

Detalles Bibliográficos
Autor principal: Patoulias, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223885/
https://www.ncbi.nlm.nih.gov/pubmed/37237403
http://dx.doi.org/10.1186/s13054-023-04501-x
_version_ 1785050047434457088
author Patoulias, Dimitrios
author_facet Patoulias, Dimitrios
author_sort Patoulias, Dimitrios
collection PubMed
description
format Online
Article
Text
id pubmed-10223885
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102238852023-05-28 Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis? Patoulias, Dimitrios Crit Care Correspondence BioMed Central 2023-05-26 /pmc/articles/PMC10223885/ /pubmed/37237403 http://dx.doi.org/10.1186/s13054-023-04501-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Patoulias, Dimitrios
Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
title Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
title_full Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
title_fullStr Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
title_full_unstemmed Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
title_short Sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: Do we really need sodium increase, especially in sepsis?
title_sort sodium-glucose co-transporter-2 inhibitors in the intensive care unit setting: do we really need sodium increase, especially in sepsis?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223885/
https://www.ncbi.nlm.nih.gov/pubmed/37237403
http://dx.doi.org/10.1186/s13054-023-04501-x
work_keys_str_mv AT patouliasdimitrios sodiumglucosecotransporter2inhibitorsintheintensivecareunitsettingdowereallyneedsodiumincreaseespeciallyinsepsis

Ejemplares similares